In a report released today, Cui Cui from Jefferies maintained a Buy rating on Innovent Biologics (IVBXF – Research Report), with a price target ...
Innovent Biologics, a biopharmaceutical company based in Shuzou, China, has agreed a collaboration with Roche to develop ...
SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...
Innovent Biologics, Inc., announced that the Center for Drug Evaluation (CDE) of China's National Medical Products ...
GlobalData on MSN7d
CDE grants BTD to Innovent’s IBI343 for pancreatic cancer"CDE grants BTD to Innovent’s IBI343 for pancreatic cancer" was originally created and published by Pharmaceutical Technology ...
Tata Technologies, a global product engineering and digital services company, announced the successful conclusion of the 2nd edition of the Tata Technologies InnoVent hackathon. Focused on leveraging ...
INNOVENT BIO (01801.HK) has issued a statement to clarify the unusual price and trading volume movements of its shares. It ...
7d
Innovent Biologics Inc. (IVBXF.OB) and Jiangsu Aosaikang Pharmaceutical Co. Ltd. or ASK Pharm announced that China's National Medical ...
Innovent & ASK Pharm Announce NMPA Approval Of Limertinib,3rd-Gen EGFR TKI For Lung Cancer Treatment
(RTTNews) - Innovent Biologics Inc. (IVBXF.OB) and Jiangsu Aosaikang Pharmaceutical Co. Ltd. or ASK Pharm announced that China's National Medical Products Administration (NMPA) has approved the ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback